Agilent ICP-MS-MS (ICP-triple quad)

Ended Awarded Last action

Contract number
75F40120F80166
Awardee
Awarding agency
Obligated
$437,702

Award facts

Opportunity
Contract value 100% obligated
$437,702.12 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Atlanta, GA 30309, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00005 $21,322
Exercise an Option P00004 $21,322
Exercise an Option P00003 $21,322
Exercise an Option P00002 $21,322
Supplemental Agreement for work within scope P00001 $0
Original award $352,412

About this award

The Food and Drug Administration awarded a $437.7K delivery order to Agilent Technologies Inc. for an ICP-MS-MS (inductively coupled plasma triple quadrupole mass spectrometer) system on April 28, 2020, with performance completion targeted for April 27, 2025. This delivery order, issued under the Scientific Equipment and Services (FSS-66) General Services Administration schedule, carries firm fixed price terms and was awarded without set-aside designation, indicating full and open competition. The equipment will be delivered to the FDA's Atlanta, Georgia location and represents a critical analytical instrument supporting the agency's food safety, drug quality, and contamination detection operations.

This procurement leverages Agilent's established expertise as a leading provider of advanced mass spectrometry instrumentation and laboratory equipment to federal agencies. The ICP-MS-MS system delivers high-sensitivity elemental and isotopic analysis capabilities essential for FDA regulatory testing and research initiatives, including pharmaceutical analysis, environmental contaminant detection, and trace metal determination in food and drug products. The award reflects Agilent's competitive positioning within the federal marketplace and the company's role as a preferred vendor for sophisticated analytical instrumentation across civilian research and regulatory agencies.

Quick answers

Who was awarded contract 75F40120F80166?

75F40120F80166 was awarded to Agilent Technologies Inc. by Food and Drug Administration (Department of Health and Human Services) on April 28, 2020.

How much is contract 75F40120F80166 worth?

The government has obligated $437,702 on 75F40120F80166.

Is contract 75F40120F80166 an order under another contract?

Yes. 75F40120F80166 is a delivery order under GS07F0564X, a federal supply schedule, on Scientific Equipment and Services (FSS-66).

Was contract 75F40120F80166 competed?

The extent of competition for 75F40120F80166 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award